GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Symmetry Surgical Inc (FRA:RZV) » Definitions » EV-to-EBIT

Symmetry Surgical (FRA:RZV) EV-to-EBIT : 264.32 (As of Jun. 23, 2024)


View and export this data going back to . Start your Free Trial

What is Symmetry Surgical EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Symmetry Surgical's Enterprise Value is €270.9 Mil. Symmetry Surgical's EBIT for the trailing twelve months (TTM) ended in Sep. 2014 was €1.0 Mil. Therefore, Symmetry Surgical's EV-to-EBIT for today is 264.32.

The historical rank and industry rank for Symmetry Surgical's EV-to-EBIT or its related term are showing as below:

FRA:RZV' s EV-to-EBIT Range Over the Past 10 Years
Min: -25.9   Med: 17.65   Max: 84.6
Current: 78.51

During the past 13 years, the highest EV-to-EBIT of Symmetry Surgical was 84.60. The lowest was -25.90. And the median was 17.65.

FRA:RZV's EV-to-EBIT is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 19.075 vs FRA:RZV: 78.51

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Symmetry Surgical's Enterprise Value for the quarter that ended in Sep. 2014 was €404.6 Mil. Symmetry Surgical's EBIT for the trailing twelve months (TTM) ended in Sep. 2014 was €1.0 Mil. Symmetry Surgical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2014 was 0.25%.


Symmetry Surgical EV-to-EBIT Historical Data

The historical data trend for Symmetry Surgical's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Symmetry Surgical EV-to-EBIT Chart

Symmetry Surgical Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.19 14.61 66.15 17.85 -19.02

Symmetry Surgical Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23.37 -19.02 -19.65 -13.10 85.48

Competitive Comparison of Symmetry Surgical's EV-to-EBIT

For the Medical Devices subindustry, Symmetry Surgical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Symmetry Surgical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Symmetry Surgical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Symmetry Surgical's EV-to-EBIT falls into.



Symmetry Surgical EV-to-EBIT Calculation

Symmetry Surgical's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=270.929/1.025
=264.32

Symmetry Surgical's current Enterprise Value is €270.9 Mil.
Symmetry Surgical's EBIT for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Symmetry Surgical  (FRA:RZV) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Symmetry Surgical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2014 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2014 ) =EBIT / Enterprise Value (Q: Sep. 2014 )
=1.025/404.593318
=0.25 %

Symmetry Surgical's Enterprise Value for the quarter that ended in Sep. 2014 was €404.6 Mil.
Symmetry Surgical's EBIT for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Symmetry Surgical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Symmetry Surgical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Symmetry Surgical (FRA:RZV) Business Description

Traded in Other Exchanges
N/A
Address
Symmetry Medical, Inc., is a Delaware corporation incorporated on July 25, 1996. It is a source of medical device products. The Company provides medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry and other medical device markets. It also manufactures specialized non-healthcare products, mainly in the aerospace industry. It operates in two reportable segments namely Original Equipment Manufacturer (OEM) Solutions and Symmetry Surgical. Its main products produced in the OEM Solutions segment include: implants, including forged, cast and machined products for the global orthopedic device market; instruments used in the placement and removal of orthopedic implants and in other surgical procedures; cases, including plastic, metal and hybrid cases used to organize, secure and transport medical devices for orthopedic, endoscopy, dental and other surgical procedures; and other specialized products for the aerospace market. Symmetry Surgical is its new business segment. It arose from the integration of the Codman and Olsen Medical lines of surgical instruments with its Company's already existing hospital direct business, Specialty Surgical Instrumentation (SSI). Symmetry Surgical, which is headquartered in Nashville, Tennessee offers reusable stainless steel and titanium surgical hand-held instruments and retractor systems, sterile disposable surgical products, and sterilization containers. These products are used in the surgical specialties of spine, general/obstetrics/gynecology, microsurgery/neurosurgery, orthopedics, and laparoscopy, cardiovascular, thoracic and general surgery in the hospital setting as well as surgery centers and in select physician offices. The Company's OEM Solutions segment has manufacturing facilities in the U.S., United Kingdom, France, Ireland and Malaysia. The Company's subject to federal, state and local environmental laws and regulations governing the emission, discharge, use, storage and disposal of hazardous materials and the remediation of contamination associated with the release of these materials at our facilities and at off-site disposal locations.

Symmetry Surgical (FRA:RZV) Headlines